BC
PFE icon

Bridgefront Capital’s Pfizer PFE Stock Holding History

Bridgefront Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
+59,596
New +$1.56M 0.38% 68
2026
Q1 		– Sell
-114,653
Closed -$2.85M – 710
2025
Q4 		$2.85M Buy
+114,653
New +$2.89M 0.72% 14
2025
Q3 		– Sell
-24,496
Closed -$594K – 770
2025
Q2 		$594K Sell
24,496
-67,775
-73% -$1.58M 0.16% 237
2025
Q1 		$2.34M Buy
92,271
+64,402
+231% +$1.69M 0.68% 7
2024
Q4 		$739K Sell
27,869
-8,594
-24% -$233K 0.25% 118
2024
Q3 		$1.06M Sell
36,463
-38,318
-51% -$1.12M 0.41% 44
2024
Q2 		$2.09M Buy
74,781
+52,419
+234% +$1.44M 0.87% 7
2024
Q1 		$621K Sell
22,362
-247
-1% -$6.85K 0.47% 43
2023
Q4 		$651K Sell
22,609
-5,756
-20% -$174K 0.49% 41
2023
Q3 		$941K Buy
28,365
+20,683
+269% +$731K 0.66% 18
2023
Q2 		$282K Buy
7,682
+1,814
+31% +$70.6K 0.15% 270
2023
Q1 		$239K Buy
+5,868
New +$253K 0.15% 280
2021
Q4 		– Sell
-9,167
Closed -$394K – 416
2021
Q3 		$394K Buy
+9,167
New +$406K 0.41% 74
2021
Q1 		– Sell
-37,822
Closed -$1.39M – 856
2020
Q4 		$1.39M Buy
+37,822
New +$1.39M 0.48% 20

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bridgefront Capital's PFE Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Pfizer (PFE) in Q2 2026: 59,596 shares worth $1.44M. The stake represents 0.38% of the portfolio and ranks #68 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in PFE as recently as Q4 2025.

Bridgefront Capital first reported a position in PFE in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.85M in Q4 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bridgefront Capital held 59,596 shares of Pfizer worth $1.44M as of Q2 2026.
  • Pfizer was a new Bridgefront Capital position in Q2 2026.
  • Pfizer made up 0.38% of Bridgefront Capital's portfolio in Q2 2026, its #68 holding.
  • Bridgefront Capital first reported a position in Pfizer in Q4 2020 and has held it in 14 quarters since.
  • Bridgefront Capital's Pfizer position peaked at $2.85M in Q4 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.